DK358283D0 - Fremgangsmade til fremstilling af pyridincarboxylsyreestere af dopamin eller dets n-alkylderivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Fremgangsmade til fremstilling af pyridincarboxylsyreestere af dopamin eller dets n-alkylderivater eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK358283D0
DK358283D0 DK3582/83A DK358283A DK358283D0 DK 358283 D0 DK358283 D0 DK 358283D0 DK 3582/83 A DK3582/83 A DK 3582/83A DK 358283 A DK358283 A DK 358283A DK 358283 D0 DK358283 D0 DK 358283D0
Authority
DK
Denmark
Prior art keywords
alkylic
dopamine
derivatives
addition salts
pharmaceutical acceptable
Prior art date
Application number
DK3582/83A
Other languages
English (en)
Other versions
DK358283A (da
Inventor
Cesare Casagrande
Emilio Mussini
Vittorio Vecchietti
Original Assignee
Simes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes filed Critical Simes
Publication of DK358283D0 publication Critical patent/DK358283D0/da
Publication of DK358283A publication Critical patent/DK358283A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
DK358283A 1982-08-06 1983-08-05 Fremgangsmaade til fremstilling af pyridincarboxylsyreestere af dopamin eller dets n-alkylderivater eller farmaceutisk acceptable syreadditionssalte deraf DK358283A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8222761A IT1210918B (it) 1982-08-06 1982-08-06 Esteri piridincarbossilici della dopamina e suoi alchie derivati

Publications (2)

Publication Number Publication Date
DK358283D0 true DK358283D0 (da) 1983-08-05
DK358283A DK358283A (da) 1984-02-07

Family

ID=11200146

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358283A DK358283A (da) 1982-08-06 1983-08-05 Fremgangsmaade til fremstilling af pyridincarboxylsyreestere af dopamin eller dets n-alkylderivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (12)

Country Link
US (1) US4644004A (da)
EP (1) EP0101633B1 (da)
JP (1) JPS5962570A (da)
AT (1) ATE23996T1 (da)
AU (1) AU1756483A (da)
CA (1) CA1234572A (da)
DE (1) DE3368051D1 (da)
DK (1) DK358283A (da)
ES (1) ES525464A0 (da)
IE (1) IE55647B1 (da)
IT (1) IT1210918B (da)
ZA (1) ZA835743B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
JPH0660141B2 (ja) * 1989-09-12 1994-08-10 三井東圧化学株式会社 ジヒドロカフェイン酸誘導体およびそれを有効成分として含有する治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2428253A (en) * 1940-03-23 1947-09-30 Werder Fritz Von Water-soluble derivatives of 2-methyl-1, 4-dihydroxy-naphthalene and processes for their production
US3904671A (en) * 1969-04-01 1975-09-09 Sterling Drug Inc Esters of 3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl aminomethyl ketones

Also Published As

Publication number Publication date
ES8502972A1 (es) 1985-02-01
EP0101633A1 (en) 1984-02-29
EP0101633B1 (en) 1986-12-03
US4644004A (en) 1987-02-17
ATE23996T1 (de) 1986-12-15
IT8222761A0 (it) 1982-08-06
ES525464A0 (es) 1985-02-01
DE3368051D1 (en) 1987-01-15
JPH0434541B2 (da) 1992-06-08
ZA835743B (en) 1984-06-27
IE55647B1 (en) 1990-12-05
AU1756483A (en) 1984-02-09
JPS5962570A (ja) 1984-04-10
DK358283A (da) 1984-02-07
CA1234572A (en) 1988-03-29
IT1210918B (it) 1989-09-29
IE831839L (en) 1984-02-06

Similar Documents

Publication Publication Date Title
DK163120C (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf
FI906438A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
FI883744A (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
ATE2427T1 (de) (dl)-16-phenoxy- und 16-substituierte phenoxy-9- keto prostatriensaeuren und derivate, verfahren zu deren herstellung und ihre pharmazeutischen zusammensetzungen.
DK162992C (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
SE7902910L (sv) 4-tiazolidinkarboxylsyror
SE7707462L (sv) Forfarande for framstellning av penicillansyraderivat
HUT52511A (en) Process for producing new substituted cephalosporine-sulfon derivatives and pharmaceutical compositions containing them as active components
SE8204312D0 (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
HUT34166A (en) Process for producing of imidazol-ethanol esthers
IT1169783B (it) Derivati dell' acido 4-fenil 4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali
DK358283A (da) Fremgangsmaade til fremstilling af pyridincarboxylsyreestere af dopamin eller dets n-alkylderivater eller farmaceutisk acceptable syreadditionssalte deraf
IT1168008B (it) Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
KR890002174A (ko) 삼환성 세팜 화합물, 그의 제조방법 및 용도
SE7906681L (sv) Ftalazonderivat
NO904708L (no) Fremgangsmaate for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksid-(1r-2r).
SE8301785D0 (sv) Procede de preparation de derives de l'acide 2-thiophene acetique et produits intermediaires necessaires pour leur preparation
DE2964850D1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
ES8407021A1 (es) Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico.
DK39981A (da) 17-amino-16-hydroxysteroider af androstan- og oestranraekken og derivater deraf fremgangsmaader til dens fremstilling og farmaceutiske produkter
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
SE8802192D0 (sv) Forfarande for framstellning av kondenserade as-trizinderivat
ATE32883T1 (de) Derivate von biphenylylalkansaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen daraus.
SE8405332D0 (sv) 2h-azeto(2,1-a)-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment